|
GENE
|
Genetic Technologies Ltd
|
US
|
NASDAQ
|
|
GERM
|
ETFMG Treatments Testing and Advancements ETF
|
US
|
AMEX
|
|
GERN
|
Geron Corporation
|
US
|
NASDAQ
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|
|
GLUE
|
Monte Rosa Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GLYC
|
GlycoMimetics, Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GMDA
|
Gamida Cell Ltd.
|
US
|
NASDAQ
|
|
GMTX
|
Gemini Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GNCA
|
Genocea Biosciences, Inc.
|
US
|
NASDAQ
|
|
GNOM
|
Global X Genomics & Biotechnology ETF
|
US
|
NASDAQ
|
|
GNPX
|
Genprex, Inc.
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
GOVX
|
GeoVax Labs, Inc.
|
US
|
NASDAQ
|
|
GRPH
|
Graphite Bio, Inc.
|
US
|
NASDAQ
|
|
GRTX
|
Galera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
GTBP
|
GT Biopharma, Inc.
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|